KRYS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Krystal Biotech Inc (KRYS).


$4.51B Market Cap.

As of 02/19/2025 5:00 PM ET (MRY) • Disclaimer

KRYS Market Cap. (MRY)


KRYS Shares Outstanding (MRY)


KRYS Assets (MRY)


Total Assets

$1.06B

Total Liabilities

$109.46M

Total Investments

$404.77M

KRYS Income (MRY)


Revenue

$290.51M

Net Income

$89.16M

Operating Expense

$204.76M

KRYS Cash Flow (MRY)


CF Operations

$123.42M

CF Investing

-$163.44M

CF Financing

$27.01M

KRYS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

KRYS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,055,838,000 (29.02%)

$818,355,000 (46.54%)

$558,450,000 (-10.83%)

$626,295,000 (101.48%)

Assets Current

$742,045,000 (26.22%)

$587,909,000 (53.19%)

$383,779,000 (-13.22%)

$442,267,000 (60.79%)

Assets Non-Current

$313,793,000 (36.17%)

$230,446,000 (31.93%)

$174,671,000 (-5.08%)

$184,028,000 (414.25%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$946,380,000 (21.54%)

$778,641,000 (49.10%)

$522,231,000 (-12.02%)

$593,576,000 (103.22%)

Property Plant & Equipment Net

$161,448,000 (-4.03%)

$168,229,000 (-0.88%)

$169,726,000 (41.93%)

$119,583,000 (249.92%)

Cash & Equivalents

$344,865,000 (-3.76%)

$358,328,000 (121.33%)

$161,900,000 (-52.56%)

$341,246,000 (27.20%)

Accumulated Other Comprehensive Income

-$190,000 (-129.78%)

$638,000 (187.64%)

-$728,000 (-346.63%)

-$163,000 (-2816.67%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$404,766,000 (71.65%)

$235,804,000 (6.27%)

$221,892,000 (37.63%)

$161,221,000 (5286.60%)

Investments Current

$252,652,000 (45.33%)

$173,850,000 (-19.98%)

$217,271,000 (124.34%)

$96,850,000 (3135.88%)

Investments Non-Current

$152,114,000 (145.53%)

$61,954,000 (1240.71%)

$4,621,000 (-92.82%)

$64,371,000 (0%)

Inventory

$26,508,000 (279.50%)

$6,985,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$104,746,000 (149.16%)

$42,040,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,985,000 (20.64%)

$4,132,000 (3.79%)

$3,981,000 (-52.60%)

$8,398,000 (298.95%)

Accumulated Retained Earnings (Deficit)

-$180,668,000 (33.04%)

-$269,827,000 (3.89%)

-$280,759,000 (-99.43%)

-$140,784,000 (-97.69%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$7,261,000 (-10.29%)

$8,094,000 (-9.39%)

$8,933,000 (11.33%)

$8,024,000 (103.35%)

Debt Current

$1,217,000 (-17.44%)

$1,474,000 (-5.57%)

$1,561,000 (49.95%)

$1,041,000 (63.17%)

Debt Non-Current

$6,044,000 (-8.70%)

$6,620,000 (-10.20%)

$7,372,000 (5.57%)

$6,983,000 (111.09%)

Total Liabilities

$109,458,000 (175.62%)

$39,714,000 (9.65%)

$36,219,000 (10.70%)

$32,719,000 (74.41%)

Liabilities Current

$101,995,000 (208.20%)

$33,094,000 (14.72%)

$28,847,000 (12.09%)

$25,736,000 (66.55%)

Liabilities Non-Current

$7,463,000 (12.73%)

$6,620,000 (-10.20%)

$7,372,000 (5.57%)

$6,983,000 (111.09%)

KRYS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$290,515,000 (473.02%)

$50,699,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$20,061,000 (548.38%)

$3,094,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$113,686,000 (15.53%)

$98,401,000 (26.59%)

$77,735,000 (92.46%)

$40,391,000 (168.15%)

Research & Development Expense

$53,573,000 (15.38%)

$46,431,000 (9.35%)

$42,461,000 (52.28%)

$27,884,000 (55.46%)

Operating Expenses

$204,759,000 (30.14%)

$157,332,000 (8.36%)

$145,196,000 (112.66%)

$68,275,000 (106.90%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$1,492,000 (0%)

Income Tax Expense

$6,197,000 (215.37%)

$1,965,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$89,159,000 (715.58%)

$10,932,000 (107.81%)

-$139,975,000 (-101.20%)

-$69,570,000 (-116.28%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$89,159,000 (715.58%)

$10,932,000 (107.81%)

-$139,975,000 (-101.20%)

-$69,570,000 (-116.28%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$89,159,000 (715.58%)

$10,932,000 (107.81%)

-$139,975,000 (-101.20%)

-$69,570,000 (-116.28%)

Weighted Average Shares

$28,592,000 (5.29%)

$27,154,190 (6.52%)

$25,491,721 (14.84%)

$22,196,846 (18.15%)

Weighted Average Shares Diluted

$29,740,000 (7.16%)

$27,751,809 (8.87%)

$25,491,721 (14.84%)

$22,196,846 (18.15%)

Earning Before Interest & Taxes (EBIT)

$95,356,000 (639.37%)

$12,897,000 (109.21%)

-$139,975,000 (-105.61%)

-$68,078,000 (-111.64%)

Gross Profit

$270,454,000 (468.12%)

$47,605,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

$65,695,000 (159.87%)

-$109,727,000 (24.43%)

-$145,196,000 (-112.66%)

-$68,275,000 (-106.90%)

KRYS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$163,439,000 (-297.78%)

$82,638,000 (172.44%)

-$114,083,000 (49.69%)

-$226,770,000 (-1928.17%)

Net Cash Flow from Financing

$27,014,000 (-86.68%)

$202,750,000 (473.60%)

$35,347,000 (-89.83%)

$347,685,000 (194.60%)

Net Cash Flow from Operations

$123,420,000 (238.98%)

-$88,804,000 (11.70%)

-$100,569,000 (-109.79%)

-$47,938,000 (-83.79%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$13,463,000 (-106.85%)

$196,428,000 (209.52%)

-$179,346,000 (-345.76%)

$72,977,000 (-9.63%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$159,201,000 (-2761.78%)

-$5,563,000 (90.90%)

-$61,104,000 (61.43%)

-$158,434,000 (-4426.43%)

Capital Expenditure

-$4,238,000 (-104.80%)

$88,201,000 (266.48%)

-$52,979,000 (22.47%)

-$68,336,000 (-360.39%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$7,960,000 (0%)

Issuance (Purchase) of Equity Shares

$32,400,000 (-84.08%)

$203,499,000 (465.34%)

$35,996,000 (-89.88%)

$355,645,000 (201.35%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$458,000 (-193.59%)

-$156,000 (-280.49%)

-$41,000 (0%)

$0 (0%)

Share Based Compensation

$49,127,000 (23.02%)

$39,933,000 (20.17%)

$33,230,000 (116.92%)

$15,319,000 (368.18%)

Depreciation Amortization & Accretion

$6,714,000 (34.09%)

$5,007,000 (23.48%)

$4,055,000 (46.44%)

$2,769,000 (49.59%)

KRYS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

93.10% (-0.85%)

93.90%

-

-

Profit Margin

30.70% (42.13%)

21.60%

-

-

EBITDA Margin

35.10% (-0.57%)

35.30%

-

-

Return on Average Equity (ROAE)

10.30% (543.75%)

1.60% (106.20%)

-25.80% (-72.00%)

-15.00% (-28.21%)

Return on Average Assets (ROAA)

9.40% (526.67%)

1.50% (106.30%)

-23.80% (-67.61%)

-14.20% (-26.79%)

Return on Sales (ROS)

32.80% (29.13%)

25.40%

-

-

Return on Invested Capital (ROIC)

18.10% (465.63%)

3.20% (108.00%)

-40.00% (20.16%)

-50.10% (59.53%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

50.21 (-83.81%)

310.15 (2249.34%)

-14.43 (35.43%)

-22.35 (36.31%)

Price to Sales Ratio (P/S)

15.42 (-76.80%)

66.45

-

-

Price to Book Ratio (P/B)

4.76 (5.94%)

4.49 (15.05%)

3.91 (49.03%)

2.62 (-35.25%)

Debt to Equity Ratio (D/E)

0.12 (127.45%)

0.05 (-26.09%)

0.07 (25.45%)

0.06 (-14.06%)

Earnings Per Share (EPS)

3.12 (680.00%)

0.4 (107.29%)

-5.49 (-75.40%)

-3.13 (-83.04%)

Sales Per Share (SPS)

10.16 (444.24%)

1.87 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

4.17 (19045.45%)

-0.02 (99.63%)

-6.02 (-14.99%)

-5.24 (-140.50%)

Book Value Per Share (BVPS)

33.1 (15.43%)

28.68 (39.97%)

20.49 (-23.39%)

26.74 (72.00%)

Tangible Assets Book Value Per Share (TABVPS)

36.93 (22.53%)

30.14 (37.57%)

21.91 (-22.36%)

28.21 (70.52%)

Enterprise Value Over EBIT (EV/EBIT)

43 (-82.30%)

243 (1969.23%)

-13 (31.58%)

-19 (32.14%)

Enterprise Value Over EBITDA (EV/EBITDA)

40.55 (-76.84%)

175.06 (1377.66%)

-13.7 (29.93%)

-19.55 (34.36%)

Asset Turnover

0.3 (323.61%)

0.07 (0%)

0 (0%)

0 (0%)

Current Ratio

7.28 (-59.05%)

17.77 (33.53%)

13.3 (-22.58%)

17.18 (-3.46%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$119,182,000 (19864.84%)

-$603,000 (99.61%)

-$153,548,000 (-32.06%)

-$116,274,000 (-184.11%)

Enterprise Value (EV)

$4,139,137,450 (32.06%)

$3,134,356,300 (68.29%)

$1,862,441,595 (45.84%)

$1,277,034,981 (41.39%)

Earnings Before Tax (EBT)

$95,356,000 (639.37%)

$12,897,000 (109.21%)

-$139,975,000 (-101.20%)

-$69,570,000 (-116.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$102,070,000 (470.10%)

$17,904,000 (113.17%)

-$135,920,000 (-108.12%)

-$65,309,000 (-115.43%)

Invested Capital

$616,239,000 (41.66%)

$435,027,000 (15.50%)

$376,636,000 (40.88%)

$267,337,000 (760.46%)

Working Capital

$640,050,000 (15.36%)

$554,815,000 (56.32%)

$354,932,000 (-14.79%)

$416,531,000 (60.45%)

Tangible Asset Value

$1,055,838,000 (29.02%)

$818,355,000 (46.54%)

$558,450,000 (-10.83%)

$626,295,000 (101.48%)

Market Capitalization

$4,505,627,450 (28.76%)

$3,499,277,300 (71.56%)

$2,039,728,595 (31.13%)

$1,555,546,981 (31.55%)

Average Equity

$867,590,250 (29.62%)

$669,317,250 (23.33%)

$542,684,500 (17.27%)

$462,751,250 (67.99%)

Average Assets

$952,277,500 (34.86%)

$706,144,500 (20.04%)

$588,256,750 (19.81%)

$490,991,000 (71.44%)

Invested Capital Average

$526,211,000 (32.34%)

$397,613,250 (13.49%)

$350,358,500 (157.88%)

$135,863,500 (423.06%)

Shares

28,760,548 (1.96%)

28,206,330 (9.55%)

25,747,647 (15.78%)

22,237,984 (12.84%)